Aurobindo Pharma Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Dec-2022	Sep-2022	Jun-2022	Mar-2022
Gross Sales	6378.67	6387.97	5673.65	6176.84	5795.34
Excise Duty	--	--	--	--	--
Net Sales	6378.67	6387.97	5673.65	6176.84	5795.34
Other Operating Income	94.29	19.16	65.72	59.08	14.03
Other Income	134.91	92.65	57.19	40.62	48.88
Total Income	6607.87	6499.78	5796.56	6276.54	5858.25
Total Expenditure	5476.64	5453.31	4949.81	5303.41	5001.84
PBIDT	1131.23	1046.47	846.75	973.13	856.41
Interest	55.60	44.96	25.29	14.63	9.21
PBDT	1075.63	1001.51	821.46	958.50	847.20
Depreciation	345.57	321.40	298.10	279.51	253.57
Minority Interest Before NP	--	--	--	--	--
Tax	580.39	136.07	165.92	189.10	10.52
Deferred Tax	(356.24)	53.03	(52.93)	(30.49)	6.97
Reported Profit After Tax	505.91	491.01	410.37	520.38	576.14
Minority Interest After NP	(0.36)	(0.25)	0.92	(0.16)	(0.32)
Net Profit after Minority Interest	506.27	491.26	409.45	520.54	576.46
Extra-ordinary Items	--	--	--	--	(157.96)
Adjusted Profit After Extra-ordinary item	506.27	491.26	409.45	520.54	734.42
EPS (Unit Curr.)	8.64	8.38	6.99	8.88	9.84
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	300	--	--	--
Equity	58.59	58.59	58.59	58.59	58.59
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	17.73	16.38	14.92	15.75	14.78
PBDTM(%)	16.86	15.68	14.48	15.52	14.62
PATM(%)	7.93	7.69	7.23	8.43	9.94

QuickLinks for Aurobindo Pharma Ltd.